Rigshospitalet Achieves Breakthrough in CNS Tumor Classification

Rigshospitalet, Copenhagen DK

Incredible advancements are taking place at Rigshospitalet Dept of Pathology! 🎉 We’re now conducting ultra-fast deep CNS tumor classification post-surgery, revolutionizing patient care. 🧠💥Massive gratitude to everyone who participated in our GridION Oxford Nanopore Technologies training. Let’s continue pushing boundaries and shaping the future of healthcare together! 💪

Dr. Andreas Venizelos
Dr. Andreas Venizelos
FIELD APPLICATIONS SCIENTIST @ OXFORD NANOPORE TECHNOLOGIES

My research interests include genomic alterations and subclonal evolution dynamics in tumours, as well as the genomic profiling of a hitherto understudied cancer type, gastroenteropancreatic neuroendocrine carcinomas (NECs).